2096:HKG
Simcere Pharmaceutical Group Ltd
HK$11.02
arrow_upward
+1.75%(+0.19) 1D
Oct 16, 4:08:14 PM GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2096...
Open
HK$10.85
High
HK$11.29
Low
HK$10.85
Mkt. cap
28.30B
Avg. vol.
4.02M
Volume
5.80M
Dividend
1.88%
Quarterly dividend
HK$0.05
Ex-dividend date
Jun 18, 2025
P/E ratio
16.54
52-wk high
HK$14.38
52-wk low
HK$9.07
EPS
HK$0.67
Shares outstanding
2.57B
No. of employees
7K
Open
HK$10.85
High
HK$11.29
Low
HK$10.85
Mkt. cap
28.30B
Avg. vol.
4.02M
Volume
5.80M
Dividend
1.88%
Quarterly dividend
HK$0.05
Ex-dividend date
Jun 18, 2025
P/E ratio
16.54
52-wk high
HK$14.38
52-wk low
HK$9.07
EPS
HK$0.67
Shares outstanding
2.57B
No. of employees
7K
News stories
From web sources and news partners
Benzinga
·
31 minutes ago
Dow Jones, Nasdaq 100, S&P 500 Outlook: Top Catalysts to Move US Stocks This Week
Yahoo Finance UK
·
4 hours ago
Yardeni Lowers S&P 500 Target to 7,900 Despite Maintaining 2027 Earnings Forecast
MarketWatch
·
4 hours ago
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
Profile
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
About Simcere Pharmaceutical Group Ltd
CEORen Jinsheng
Employees7.06K
Founded1995
HeadquartersNanjing, Jiangsu, China
SectorPharmaceutical industry
Websitesimcere.com